Sigma-Aldrich
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Product Lines
Product Highlights
New Literature
Ion Channels
Key Resources
Cell Signaling Web Tools
New Products
PathFinder
Pathway Slides & Charts
Pharm. Action Table
Poster Gallery
Protocols
Search Tools
eHandbook
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 

Angiopoietins and their receptors, Tie1 and Tie2

Top Border
Left Border  Right Border
Left Corner Back Download Forward Sigma-Aldrich Right Corner

Angiopoietins and their receptors, Tie1 and Tie2

The angiopoietins were originally discovered as ligands for Tie receptors, a family of receptor tyrosine kinases (RTKs) that are selectively expressed within the vascular endothelium. + or - indicates either activation or antagonism of the Tie2 receptor by the individual angiopoietins. Potential interactions between the Tie1 receptor and the various angiopoietins have not yet been confirmed.

The Eph RTKs compromise the largest known family of growth factor receptors and are bound by the large family of ephrin ligands. The ephrins must be tethered to the membrane in order to activate their respective Eph receptors. Thus, they mediate cell:cell interactions. The signaling cascade can go both through the ligand and through the receptor. Only the several members that have been shown to be involved in vascular growth are displayed.

Back to Top

References:

Beecken, W.D., et al., New molecular mediators in tumor angiogenesis. J. Cell. Mol. Med., 4, 262-269 (2000).

Cheng, N., et al., The ephrins and Eph receptors in Angiogenesis. Cytokine Growth Factor Rev., 13, 75-85 (2002).

Partanen, J., and Dumont, D.J., Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Curr. Top. Microbiol. Immunol., 237, 159-172 (1999).